Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic Ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins. — CFSMEATLAS
Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic Ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins.
Hokama, Yoshitsugi, Empey-Campora, Cara, Hara, Cynthia et al. · Journal of clinical laboratory analysis · 2008 · DOI
Quick Summary
This study looked for specific molecules in the blood of ME/CFS patients that might be related to mitochondria (the energy-producing parts of cells). Researchers found that over 91% of ME/CFS patients had elevated levels of these molecules, similar to what was seen in people with other conditions linked to toxins. The study suggests these molecules might be a biological marker—like a sign—of ME/CFS, comparable to well-known inflammation markers in other diseases.
Why It Matters
This research provides preliminary evidence that ME/CFS may involve detectable immune responses to mitochondrial lipids, which could eventually help develop a blood-based biomarker for diagnosis. Understanding shared molecular features with toxin-related illnesses may illuminate common pathogenic pathways. These findings could support recognition of ME/CFS as a biomedically measurable condition.
Observed Findings
91.2% of CFS sera showed elevated titers (≥1:40) in the modified MIA assay
87.8%–90.2% of tested CFS samples demonstrated anti-cardiolipin (aCL) antibodies, predominantly IgM type
Gulf War Veterans showed 100% positivity and CCFP patients showed 76% positivity for elevated titers, suggesting overlap with other toxin-related illnesses
92.3% of normal sera showed low titers (≤1:20), supporting potential specificity of elevated titers
Inhibition analyses showed phospholipids in cardiolipin and CTX are antigenically similar to antibodies from CFS patient sera
Inferred Conclusions
CFS is associated with detectable 'acute phase lipids'—phospholipids related to mitochondrial cardiolipin—that may serve as a biomarker analogous to acute phase proteins in inflammatory diseases
The overlap in these phospholipids across CFS, CCFP, and Gulf War illness suggests a shared or common immunological response across toxin- and infection-related conditions
The predominance of IgM antibodies suggests an active or ongoing immune response to these lipid antigens
Remaining Questions
Do these anti-cardiolipin antibodies have functional consequences for mitochondrial function or cellular energy metabolism?
What This Study Does Not Prove
This study does not establish that these phospholipids cause ME/CFS or prove they are disease-specific—similar markers appear in other conditions. Cross-sectional design means causality cannot be determined, and the clinical significance of these antibodies remains unclear. The study does not validate these markers as diagnostic tests or show they correlate with symptom severity or disease progression.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Are these phospholipids elevated before symptom onset, and do they correlate with disease severity or remission?
What triggers the generation of these antibodies—infection, toxin exposure, or autoimmune dysregulation—and can this mechanism be targeted therapeutically?
How specific are these markers to ME/CFS, CCFP, and Gulf War illness versus other chronic conditions?